Deciphera Pharmaceuticals, LLC
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Deciphera Pharmaceuticals, LLC
RECRUITINGPhase 1NCT06966024
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
This is a multicenter clinical trial to evaluate the safety and preliminary activity of the selective general control nonderepressible 2 (GCN2) activator DCC-2812 as monotherapy...
Sponsor: Deciphera Pharmaceuticals, LLCEnrolling: 603 locations
Renal Cell CarcinomaUrothelial CarcinomaCastration-resistant Prostate Cancer
RECRUITINGPhase 2NCT06619561
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
The purpose of this study is to determine if vimseltinib is safe, tolerable and works effectively to treat adults with active moderate to severe cGVHD. Participants will be...
Sponsor: Deciphera Pharmaceuticals, LLCEnrolling: 4820 locations
Chronic Graft-Versus-Host Disease (cGVHD)